Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Semaglutide is prescribed for: Weight loss in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) Weight loss in adult patients with an initial body mass index (BMI) of 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (hypertension, type 2 diabetes mellitus, or dyslipidemia) Weight loss in pediatric patients aged 12 years and older with an initial BMI at the 95th percentile or greater for age and sex (obesity) Reducing the risk of major adverse cardiovascular events (non-fatal myocardial infarction, CV death, or non-fatal stroke) in adults with cardiovascular disease and either obesity or overweight Treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), formerly known as NASH, with moderate to advanced liver fibrosis (stages F2 to F3 fibrosis) in adults Patients taking semaglutide for any of these conditions, especially weight loss, are typically suggested to maintain a low-carb and low-fat diet
This service is billed using CPT code 87804
Its still early days, though, and many presumptions regarding its safety, distribution, and long-term consequences require thorough evaluation
It is not permitted for human or veterinary administration
I actually feel human again and when I went back later in the day to thank everyone they agreed that I looked like a different person, lol I sure wish this team was in my home town as Id utilize them definitely more often
We demonstrate applicability beyond 5FU treatment in CRC to any TS-targeted therapeutics in other disease subtypes
